You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

Litigation Details for Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-01-06 14 Answer to Complaint United States Patent Nos. 8,101,659 (the “’659 patent”), 8,796,331 (the “’331 patent”), and 8,877,938…103 mg, prior to the expiration of U.S. Patents Nos. 8,101,659 (the Case 1:19-cv-02021-LPS Document…and every asserted claim of United States Patent No. 8,101,659 is invalid for failing to satisfy one or… and enforceable asserted claim of U.S. Patent No. 8,101,659. …entered that each claim of United States Patent Nos. 8,101,659, 8,796,331, and 8,877,938 is invalid; External link to document
2022-08-26 196 ~Util - Set Hearings AND Order validity of U.S. Patent Nos. 8,101,659 (the 659 patent) and 8,796,331 (the 331 patent) is scheduled for…validity of U.S. Patent Nos. 8,877,938 (the 938 patent) and 9,388,134 (the 134 patent) is scheduled for…2019 7 February 2024 1:19-cv-02021 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2022-11-04 226 Stipulation-General (See Motion List for Stipulation to Extend Time) Order Regarding Post-Trial Briefing for U.S. Patent No. 8,796,331 by Novartis Pharmaceuticals Corporation.…2019 7 February 2024 1:19-cv-02021 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.